VKH
AZN icon

Virtu KCG Holdings’s AstraZeneca AZN Stock Holding History

Virtu KCG Holdings’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-16,500
Closed -$1.07M – 3628
2014
Q1 		$1.07M Sell
16,500
-6,500
-28% -$420K 0.01% 1175
2013
Q4 		$1.37M Buy
23,000
+18,600
+423% +$1.01M 0.02% 935
2013
Q3 		$228K Buy
+4,400
New +$221K ﹤0.01% 2953

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Virtu KCG Holdings's AZN Position: Q2 2017 in Review

Virtu KCG Holdings increased its AstraZeneca (AZN) stake by 11% in Q2 2017, buying an estimated $111K and bringing the position to 17,412 shares worth $1.19M. The position accounts for 0.03% of the portfolio, ranked #483.

Virtu KCG Holdings first reported a position in AZN in Q3 2013 and has held it in 15 quarters since. The position peaked at $34.1M in Q4 2013. 465 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

  • Virtu KCG Holdings held 17,412 shares of AstraZeneca worth $1.19M as of Q2 2017.
  • Virtu KCG Holdings bought 1,694 AstraZeneca shares in Q2 2017, an estimated $111K.
  • AstraZeneca made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #483 holding.
  • Virtu KCG Holdings first reported a position in AstraZeneca in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's AstraZeneca position peaked at $34.1M in Q4 2013.
  • 465 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.